Generic combo diabetes pill could offer cheaper alternative to Brand-Name drug
NCT ID NCT07691203
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This trial compares a generic extended-release tablet containing three diabetes drugs (empagliflozin, linagliptin, and metformin) to the brand-name Trijardy XR. The study involves 36 healthy adults who take a single dose of each version under fed conditions to see if the generic releases the same amount of medication into the bloodstream. The goal is to prove the generic works just as well, potentially offering a more affordable treatment option for people with type 2 diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- empagliflozin, linagliptin, and metformin hydrochloride extended-release tablet
- What this could lead to
- If successful, this could provide a more affordable generic version of a three-in-one diabetes medication, helping patients manage blood sugar and reduce cardiovascular risk.
- What could go wrong
- This is an early-phase bioequivalence study in healthy volunteers, not patients. Even if the generic matches the brand in absorption, it does not guarantee long-term safety or effectiveness in people with diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cliantha Research Limited
Ahmedabad, Sarkhej, 382210, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Student pharmacists may hold the key to better diabetes control in older asian adults
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Bedside flu shot for heart patients: a simple strategy to save lives?
- Can a blood vessel drug beat aspirin at preventing heart attacks in diabetes?
- Zapping lung nerves could ease heart Failure-Related high blood pressure
- Heart caregivers get a lifeline: coaching program aims to ease stress and boost mental health